Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Jan 9;8(5):678–695. doi: 10.1002/wnan.1387

Figure 3.

Figure 3

Evaluation of the ability of nanochains to target invasive brain tumors in mice. At 8 days after orthotopic inoculation of CNS-1 cells in mice, the animals were injected with various formulations of doxorubicin (DOX) at a dose 0.5 mg/kg DOX. At 24 h after injection, animals were euthanized, brain tumors were excised and DOX content was measured. (reprinted with permission after partial modifications from ref. 12)